HealthEquity’s (HQY) Outperform Rating Reiterated at Barrington Research

Barrington Research reaffirmed their outperform rating on shares of HealthEquity (NASDAQ:HQY) in a report published on Thursday,Benzinga reports. They currently have a $125.00 price target on the stock.

Other equities analysts have also issued research reports about the stock. BTIG Research restated a “buy” rating and set a $130.00 price objective on shares of HealthEquity in a research report on Thursday. BMO Capital Markets restated a “market perform” rating on shares of HealthEquity in a report on Thursday. Jefferies Financial Group lifted their price target on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. Citizens Jmp increased their price objective on HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a research report on Thursday. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $120.43.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $94.51 on Thursday. The stock has a market cap of $8.07 billion, a price-to-earnings ratio of 43.35, a PEG ratio of 1.36 and a beta of 0.18. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.23. HealthEquity has a 12 month low of $74.07 and a 12 month high of $116.65. The stock’s 50 day moving average price is $96.37 and its 200 day moving average price is $96.82.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same quarter in the previous year, the business earned $0.78 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts anticipate that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president directly owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. The trade was a 1.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 10,781 shares of company stock valued at $1,016,707 over the last three months. Insiders own 1.50% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. raised its position in shares of HealthEquity by 50.6% in the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock valued at $216,171,000 after purchasing an additional 821,425 shares during the period. Norges Bank acquired a new position in HealthEquity in the 2nd quarter valued at $75,072,000. Westfield Capital Management Co. LP raised its holdings in HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after acquiring an additional 701,819 shares during the period. AQR Capital Management LLC raised its holdings in HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after acquiring an additional 661,795 shares during the period. Finally, Nuveen LLC acquired a new position in HealthEquity during the 1st quarter worth $53,076,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.